In relation to the peer group over the last 90 days, insider buy/sell trading at Fate Therapeutics is greater than the 324-company peer group average. Bio Therapeutic Drugs peer group saw 464 buy/sell trades during this period for an average of 1.4 transactions per company. The number of shares per buy/sell trade for Fate Therapeutics insiders was also higher. Within the peer group there were 123,310,198 shares purchased and 20,598,285 shares sold with company insiders purchasing 384,689 shares on average.
To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data obtained to evaluate and write this story.
|ArcelorMittal's Acquisition of Essar Steel Put on Ho...|
|Market Chatter: Steep Corn Prices, Trade War Could D...|
|Netflix, Actors' Union Sign 3-Year Contract Broadeni...|
|Lockheed Martin to Build THAAD Missile Defense Syste...|
|Novartis' Sandoz Initiates Clinical Study of Propose...|